Limerick: forever associated with five lines of rhyme or infamous for irrepressible carbapenemase-producing Enterobacteriaceae for all time?

Journal of Hospital Infection

Volumn 93, Issue 2, 2016, Pages 155-156

  O'Connor, C ^a,b   O'Connell, N H ^a,b   Commane, M ^a   O'Donovan, E ^a   Power, L ^a   Dunne, C P ^b  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CHLORHEXIDINE GLUCONATE; IMIPENEM; LINEZOLID; METALLO BETA LACTAMASE; OXACILLIN; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CITROBACTER FREUNDII; CLINICAL PRACTICE; DISINFECTION; DRUG USE; ENTEROBACTERIACEAE INFECTION; FECES ANALYSIS; GRAM NEGATIVE BACTERIUM; HOSPITAL HYGIENE; HUMAN; INCIDENCE; INFECTION CONTROL; IRELAND; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LETTER; MEDICAL AUDIT; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRESCRIPTION; PREVALENCE; SCREENING TEST; SEASONAL VARIATION; STAPHYLOCOCCUS EPIDERMIDIS; UNIVERSITY HOSPITAL; CITY; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; SECRETION (PROCESS);

BACTERIAL PROTEINS; BETA-LACTAMASES; CITIES; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS; HUMANS; INFECTION CONTROL; IRELAND;

EID: 84963958058     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.03.008     Document Type: Letter

References (8)

1. 1 Gray, J.W., Mahida, N., How do you solve a problem like multidrug-resistant Gram-negative bacteria?. J Hosp Infect 92 (2016), 1–2.
2. 2 Wilson, A.P., Livermore, D.M., Otter, J.A., et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect 92:Suppl 1 (2016), S1–S44.
3. 3 Roche, C., Cotter, M., O'Connell, N., Crowley, B., First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill, 14, 2009 pii=19163.
4. 4 O'Connor, C., Powell, J., Finnegan, C., et al. Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland. J Hosp Infect 90 (2015), 316–321.
5. 5 Burns, K., Morris, D., Murchan, S., et al. Carbapenemase-producing Enterobacteriaceae in Irish critical care units: results of a pilot prevalence survey, June 2011. J Hosp Infect 83 (2013), 71–73.
6. 6 Morris, D., Boyle, F., Morris, C., et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 67 (2012), 2367–2372.
7. 7 Veterinary Medicines Directorate. Cascade use of authorised medicines. Available at: http://www.vmd.defra.gov.uk/pdf/vmgn/vmgnote13.pdf [last accessed March 2016].
8. 8 Schwaber, M.J., Lev, B., Israeli, A., et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumonia in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52 (2011), 848–855.